StockData
CVRXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

CVRx, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$1.35+0.05 (+3.85%)

Close on Oct 19, 2026

Market cap
$35.80M
P/E (TTM)
–
Dividend yield
–

CVRx, Inc. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
86.9%
Operating margin
-79.5%
Net margin
-84.9%
Return on equity, FY2025
-96.6%

Financial strength

Current ratio
8.04
Debt to equity
2.94
Debt to assets
63.5%
Cash to current liabilities
580.6%

Valuation

P/E ratio
–
Price to sales
0.59
Price to book
1.79
Dividend yield
–